Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

Part of paid clinical trials in Portland, Oregon.

Sponsor
OHSU Knight Cancer Institute
Study ID
NCT06562777
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-Interventional Study

Study Details

This study aims to learn more about symptoms that patients experience while receiving immunotherapy for cancer.

Key Dates

Start date
Sep 15, 2023
Status verified
Oct 2025
Primary completion
Mar 1, 2026
Completion
Mar 1, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Observational
    Patients complete surveys and have their medical records reviewed on study.

Primary Outcome Measure

Patient-reported symptoms [ Time Frame: Baseline, weekly thereafter up to 26 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
OHSU Knight Cancer InstitutePortlandOregon97239
Deanne Tibbitts
[email protected]
503-494-4361
Deanne Tibbitts (PRINCIPAL_INVESTIGATOR)

Find similar trials in Portland, OR

By research site
OHSU Knight Cancer Institute· Portland, OR

Related Studies